Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04114942 · ClinicalTrials.gov registry record · NA
PEERS© for Careers
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT04114942: Completed NA study, sponsored by University of California, Los Angeles.
NCT04114942 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04114942, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The current study proposes to investigate the effectiveness of PEERS© adapted to target postsecondary students with ASD as they prepare for careers (PEERS© for Careers). Building upon the PEERS© evidence base, PEERS© for Careers will target the development of social competence and related skills as they pertain to the work setting in a 20-week didactic course and subsequent 10-week internship. In the first phase of the study, participants will be randomized to be paired with a career coach to support practicing and generalizing the skills learned within the didactics portion of the program or to receive the didactic training without a career coach. In the second phase of the study, participants who were randomized to receive the didactic training with a coach will continue to receive coaching during the following 10-week internship phase. Those who completed the didactic training without a coach will be re-randomized to either a career coach or no coach condition and will complete a 10-week internship as well.
Primary Outcome
The Test of Employment Social Skills (TESS) is a novel, 36-item criterion-referenced measure created to assess young adults' knowledge of the specific social and employment-related skills taught during the intervention. Changes from baseline in TESS scores after 20-week didactic, 10-week internship, and 10-week follow-up will be compared across different interventions.
Interventions
- BEHAVIORAL Never Coach
- BEHAVIORAL Internship Only Coach
- BEHAVIORAL Constant Coach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2022-10-28 |
| Phase | NA |
What the finished NCT04114942 record still lists
NCT04114942 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 3 interventions - of which Never Coach is the first listed.
NCT04114942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04114942 about?
NCT04114942 is a clinical study titled "PEERS© for Careers". The current study proposes to investigate the effectiveness of PEERS© adapted to target postsecondary students with ASD as they prepare for careers (PEERS© for Careers). Building upon the PEERS© evidence base, PEERS© for Careers will target the development of social competence and related skills as ...
What is the current status of trial NCT04114942?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2020-01-01. Estimated completion is 2022-10-28.
What interventions are being tested in trial NCT04114942?
The interventions under investigation include: Never Coach (BEHAVIORAL), Internship Only Coach (BEHAVIORAL), Constant Coach (BEHAVIORAL).
Who is sponsoring clinical trial NCT04114942?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04114942's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI